| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―04 |
Correspondence: New-onset hypertension in COVID-19 patients |
|
| 2 |
[GO] |
2024―Nov―06 |
Transient T-wave oversensing as a result of COVID-19: a case report |
|
| 3 |
[GO] |
2024―Jun―11 |
Cardiovascular disease development in COVID-19 patients admitted to a tertiary medical centre in Iran |
|
| 4 |
[GO] |
2023―Jun―13 |
Evaluating the impact of the COVID-19 pandemic on the delivery and efficiency of cardiac rehabilitation |
|
| 5 |
[GO] |
2023―May―02 |
Concurrent left ventricular and left anterior coronary artery thrombus: is COVID-19 an innocent bystander? |
|
| 6 |
[GO] |
2023―Apr―04 |
The role of vitamin D/calmodulin/calcium signalling/ACE2 pathway in COVID-19 |
|
| 7 |
[GO] |
2022―Nov―29 |
Patient satisfaction with telephone consultations in cardiology outpatients during the COVID-19 pandemic |
|
| 8 |
[GO] |
2022―Nov―09 |
COVID-19 related myopericarditis and cardiac tamponade: a diagnostic conundrum |
|
| 9 |
[GO] |
2022―Aug―30 |
An audit comparing management of patients with HFrEF at a DGH before and during the COVID-19 pandemic |
|
| 10 |
[GO] |
2022―Aug―30 |
SARS-CoV-2 dilated cardiomyopathy |
|
| 11 |
[GO] |
2022―May―31 |
Evaluation of the prognostic value of the admission ECG in COVID-19 patients: a meta-analysis |
|
| 12 |
[GO] |
2022―Mar―07 |
Pipedreams, the pandemic and PoTS: is the post-COVID-19 era a turning point for PoTS services? |
|
| 13 |
[GO] |
2022―Jan―26 |
Effect of the COVID-19 pandemic on ST-elevation myocardial infarction presentation and survival |
|
| 14 |
[GO] |
2021―Nov―30 |
Piloting structured focused TTE in outpatients during the COVID-19 pandemic: ‘old habits die hard |
|
| 15 |
[GO] |
2021―Oct―13 |
Analysis of the trend in community prescribing of RAAS inhibitors during the COVID-19 pandemic |
|
| 16 |
[GO] |
2021―Jun―01 |
ECG changes in hospitalised patients with COVID-19 infection |
|
| 17 |
[GO] |
2021―Apr―21 |
The primary prevention implantable cardioverter-defibrillator (ICD) during the COVID-19 pandemic |
|
| 18 |
[GO] |
2021―Mar―09 |
COVID-19: treatments and the potential for cardiotoxicity |
|
| 19 |
[GO] |
2020―Dec―18 |
Adapting cardiovascular disease care to the ‘new norm’ of the COVID-19 era: same standard, different delivery |
|
| 20 |
[GO] |
2020―Oct―16 |
Neprilysin inhibitors and angiotensin(1-7) in COVID-19 |
|
| 21 |
[GO] |
2020―Sep―03 |
Joint BACPR/BDA/PHNSG statement on nutrition and cardiovascular health post-COVID-19 pandemic |
|
| 22 |
[GO] |
2020―Jun―11 |
COVID-19 and cardiac rehabilitation |
|
| 23 |
[GO] |
2020―Jun―11 |
COVID-19 and immunology |
|
| 24 |
[GO] |
2020―Jun―11 |
Impact of COVID-19 on primary percutaneous coronary intervention centres in the UK: a survey |
|
| 25 |
[GO] |
2020―Jun―11 |
Catheter lab activity and COVID-19: damned if you do and... |
|
| 26 |
[GO] |
2020―Jun―11 |
COVID-19: the heart and other issues |
|
